Bio-Thera Solutions
China - GuangzhouBiotechnology
Focus: Bio-Thera Solutions is a China-based biotechnology company founded in 2019 specializing in biosimilars for oncology and immunology indications. The company has advanced products in growth/launch phases and a deep pipeline of 30+ programs across multiple therapeutic areas.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Bio-Thera Solutions
AI assessmentNot HiringNo open roles listed right now. Follow Bio-Thera Solutions to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growth
Bevacizumab biosimilar in growth phase targeting VEGF-mediated angiogenesis; highest commercial maturity asset with multi-indication label across major oncology segments.
Help build intelligence for Bio-Thera Solutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.